Nesuparib

CAS No. 2055357-64-5

Nesuparib( —— )

Catalog No. M35605 CAS No. 2055357-64-5

Nesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 233 In Stock
5MG 211 In Stock
10MG 337 In Stock
25MG 605 In Stock
50MG 807 In Stock
100MG 1097 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nesuparib
  • Note
    Research use only, not for human use.
  • Brief Description
    Nesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.
  • Description
    Nesuparib is a potent inhibitor of PARP. Nesuparib is useful for the research of neuropathic pain, neurodegenerative disease, and cardiovascular disease (extracted from patent WO2016200101A2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    Wnt/beta-catenin | PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2055357-64-5
  • Formula Weight
    400.48
  • Molecular Formula
    C23H24N6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 62.5 mg/mL (156.06 mM )
  • SMILES
    O=c1[nH]c2cc(CN3CCN(CC3)c3ccc(cn3)C#N)ccc2c2NCCCc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same. Patent WO2016200101A2.
molnova catalog
related products
  • TNKS-2-IN-2

    TNKS-2-IN-2 is a novel and potent TNKS2 selective inhibitor (IC50: 22 nM) with potential anti-tumour activity for studying colon cancer, lung cancer, and breast cancer.

  • Wnt pathway inhibito...

    Wnt pathway inhibitor 3 is a potent AC1 inhibitor (IC50: 45 nM) with antiproliferative activity, suitable for studies to ameliorate osteoarthritis in a mouse model of experimental osteoarthritis.

  • WAY-328173

    WAY-328173 is a Wnt/beta-catenin agonist.